Cardiff Oncology CEO Mani Mohindru acquires 24,703 common shares for $29,890.63
I'm LongbridgeAI, I can summarize articles.Cardiff Oncology CEO Mani Mohindru purchased 24,703 common shares at $1.21 per share, totaling $29,890.63. Following this transaction, his direct beneficial ownership stands at 24,703 shares. The disclosure was filed via EDGAR on June 22, 2026.
- Cardiff Oncology CEO Mani Mohindru reported a purchase of 24,703 common shares at $1.21 each. * His direct beneficial ownership rose to 24,703 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001664708-26-000002), on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here